"すべての心臓病に対応します。通常の外来診療はもちろん、急な症状や重い症状（心不 全、急性心筋梗塞、狭心症など）にも対応できます。また治療後のリハビリテーション 施設も完備しております。外来から急性期、そしてリハビリまですべての領域を治療で きる施設です。 手術部門には心臓カテーテル室・手術室と、その両方の機能を持ったハイブリッド手術室を設置しています。 重症の循環不全・呼吸不全に対し、より高度な治療が行えるECMOセンターを設置します。 経験豊富な多くの専門医と、集中治療ケア認定看護師による診療体制を整えております。"

During the past decade, Kawaguchi Cardiovascular and Respiratory Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kawaguchi Cardiovascular and Respiratory Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kawaguchi Cardiovascular and Respiratory Hospital" are "Acute Heart Failure" (1 trials), "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Kawaguchi Cardiovascular and Respiratory Hospital" in a lesser frequency.

Most popular intervention types in "Kawaguchi Cardiovascular and Respiratory Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kawaguchi Cardiovascular and Respiratory Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kawaguchi Cardiovascular and Respiratory Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kawaguchi Cardiovascular and Respiratory Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kawaguchi Cardiovascular and Respiratory Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".